Antineoplastic Agents

Antineoplastic Agents

1st Edition - January 1, 1981

Write a review

  • Editors: Stanley T. Crooke, Archie W. Prestayko
  • eBook ISBN: 9781483267913

Purchase options

Purchase options
DRM-free (PDF)
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

Cancer and Chemotherapy, Volume III: Antineoplastic Agents is a collection of articles that deals with the treatment of cancer using drugs. The collection describes the various drugs that are used, the therapeutic approaches being taken, and agents that are being developed. Part I is a general review of anti-cancer drugs as regards their action mechanisms, pharmacokinetics, pharmacology, known toxicities, and clinical utility. These drugs include alkylating agents such as mitomycin C and nitrosoureas; plant alkaloids such as maytansine; antibiotics such as anthracyclines; platinum-containing complexes; antimetabolites; and hormones. Part II examines the molecular pharmacology of some major drug classes, namely, bleomycin and anthracycline. The text also discusses the chemistry, mechanism, and any structure-activity relationships found in these drug classes. Part III discusses in detail the clinical pharmacology of some antitumor drugs, for example, cisplatin and nitrosoureas. The text includes the clinical applications, biochemistry, metabolism, and the use of mathematical models in interpreting or describing resulting data. The book is helpful for pharmacologists, molecular biologists, and scientists involved in cancer-research.

Table of Contents


  • List of Contributors

    General Preface

    Preface to Volume III

    Part I General Reviews

    1 Nucleoside Analogues

    I. Introduction

    II. Cytosine Arabinoside

    III. 5-Azacytidin

    IV. 5-Fluorouracil

    V. Other 5-Fluoro Pyrimidines

    VI. 3-Deazauridine

    VII. Purine Analogs

    VIII. Arabinosyl Adenine

    IX. Conclusions

    References

    2 Cyclophosphamide and Analogues

    I. Introduction

    II. Structure and Metabolism

    III. Clinical Pharmacology

    IV. Toxicities

    V. Clinical Activity and Dose Schedules

    VI. Analogues

    References

    3 Nitrosoureas

    I. Introduction

    II. Decomposition and Metabolism

    III. Mechanism of Action

    IV. Clinical Use

    V. Clinical Toxicities

    VI. Discussion

    References

    4 Mitomycin C - An Overview

    I. Introduction

    II. Chemistry

    III. Structure-Activity Relationships

    IV. Molecular Pharmacology

    V. Pharmacology

    VI. Clinical Effects

    VII. Conclusions

    References

    5 Other Alkylating Agents

    I. Introduction

    II. Mechanism of Action

    III. Other Alkylating Agents

    IV. Conclusions

    References

    6 The Vinca Alkaloids and Similar Compounds

    I. The Vinca Alkaloids

    II. The Podophyllotoxin Derivatives

    III. Maytansine

    References

    7 Bleomycin - An Overview

    I. Introduction

    II. Chemistry

    III. Molecular Pharmacology

    IV. Clinical Pharmacology

    V. Clinical Activities

    VI. Clinical Toxicities

    VII. Conclusions

    References

    8 The Anthracyclines

    I. Introduction

    II. Chemistry

    III. Molecular Pharmacology

    IV. Clinical Pharmacology

    V. Clinical Activities of Adriamycin and Daunorubicin

    VI. Toxicities of Adriamycin

    VII. Anthracyclines in Development

    References

    9 Cisplatin and Analogues: A New Class of Anticancer Drugs

    I. Introduction

    II. Antitumor Activity in Animal Tumors

    III. Animal Toxicology

    IV. Efficacy

    V. Toxicity

    VI. Cisplatin Analogues

    VII. Conclusion

    References

    10 Investigational Cancer Drugs

    I. Introduction

    II. Alkylating Agents

    III. Anthracycline Analogues

    IV. Tubulin Binding Agents

    V. Antitumor Antibiotics

    VI. Nitrosoureas

    VII. Antimetabolites

    VIII. Miscellaneous

    IX. Summary

    References

    11 Hormone Therapy

    I. Basis of Endocrine Therapy

    II. Prostatic Cancer

    III. Breast Cancer

    IV. Cancer of the Uterine Endometrium

    V. Lymphomas

    VI. Summary

    References

    12 A Human Tumor Stem Cell System: Concepts, Methodology, and Application

    I. Introduction

    II. Methodology

    III. Applications

    IV. Conclusions

    References

    Part II Molecular Pharmacology of Selected Antineoplastic Agents

    13 The Molecular Pharmacology of Bleomycin

    I. Introduction

    II. Chemistry

    III. The Interactions of Metals with Bleomycin and Analogues

    IV. Effects of Bleomycin on Isolated DNA

    V. Cellular Effects

    VI. Effects on the Cell Cycle

    VII. Morphological Effects

    VIII. Intracellular Fate and Metabolism

    IX. Conclusions

    References

    14 Molecular Pharmacology of Anthracycline Antitumor Antibiotics

    I. Introduction

    II. Chemistry

    III. Studies on the Mechanism of Action of Anthracyclines

    IV. Anthracycline Structure-Activity Relationships

    V. Conclusions

    References

    15 Vinca Alkaloids: Molecular and Clinical Pharmacology

    I. Introduction

    II. Molecular Structure

    III. Molecular Pharmacology

    IV. Clinical Pharmacology

    V. Conclusion

    References

    16 Molecular Pharmacology of Alkylating Agents

    I. Introduction

    II. Chemistry of the Alkylating Reactions

    III. Clinically Effective Alkylating Agents

    IV. Reactions with Biological Molecules

    V. Discussion

    References

    17 Molecular Pharmacology of Cisplatin

    I. Introduction

    II. Chemistry

    III. Biochemistry and Mechanism of Action

    IV. Conclusion

    References

    18 Methotrexate: Molecular Pharmacology

    I. Introduction

    II. Chemistry

    III. Mechanism of Action and Structure-Activity Relationships

    IV. Transport of Methotrexate and Related Compounds

    V. Mechanisms of Resistance to Folate Antagonists

    VI. The Future for Folate Antagonists

    References

    Part III Clinical Pharmacology of Selected Neoplastic Agents

    19 Introduction to Clinical Pharmacology

    I. Introduction

    II. Pharmacokinetics

    III. Mathematical Modeling

    IV. Clinical Correlations of Pharmacokinetics

    V. Discussion

    References

    20 Clinical Pharmacology of Bleomycin

    I. Introduction

    II. Newer Clinical Pharmacological Assays for Bleomycin

    III. Absorption

    IV. Distribution

    V. Elimination

    VI. Conclusions

    References

    21 Clinical Pharmacology of Cisplatin

    I. Introduction

    II. Cisplatin Pharmacokinetics

    III. Cisplatin Stability

    IV. Conclusion

    References

    22 Methotrexate: Clinical Pharmacology and Therapeutic Application

    I. Introduction

    II. Pharmacology

    III. Clinical Applications

    IV. Discussion

    References

    23 Clinical Pharmacology of Nitrosoureas

    I. Introduction

    II. Molecular Structure

    III. Biochemistry and Metabolism

    IV. Clinical Pharmacology

    V. Discussion

    References

    Index

Product details

  • No. of pages: 414
  • Language: English
  • Copyright: © Academic Press 1981
  • Published: January 1, 1981
  • Imprint: Academic Press
  • eBook ISBN: 9781483267913

About the Editors

Stanley T. Crooke

Archie W. Prestayko

Ratings and Reviews

Write a review

There are currently no reviews for "Antineoplastic Agents"